| Stephen Chapman |
Stephen Chapman is currently the Chief Executive Officer & Director at Natera, Inc. He previously worked as a Regional Manager at Genzyme Corp. from 2003 to 2010. He also held a position as a Principal at the University of California, Los Angeles. Mr. Chapman completed his undergraduate degree at the University of California, Los Angeles. |
| Alexey Aleshin |
Alexey Aleshin is currently the Chief Medical Officer at Natera, Inc. He holds an MBA and a doctorate from the University of California. |
| Michael Burkes Brophy |
Michael Burkes Brophy is currently the Chief Financial & Accounting Officer at Natera, Inc. He also holds the position of Chief Financial Officer at Natera, Inc. since 2017. Previously, he worked as an Executive Director at Morgan Stanley from 2014 to 2015. He also served as an Independent Director at Health Sciences Acquisitions Corp. 2. Mr. Brophy holds an MBA from the University of California, Los Angeles, which he obtained in 2007. He completed his undergraduate degree at the United States Air Force Academy in 2002. |
| Rishi Kacker |
Rishi Kacker is the founder of Voltage Security, Inc. (founded in 2002) and Myriad Women's Health, Inc. (founded in 2007). At Myriad Women's Health, he held the title of Director & Senior Vice President-Technology from 2007 to 2018. Currently, he is the Chief Technology Officer at Natera, Inc. He previously served as the Chief Technology Officer at Myriad Genetics, Inc. from 2018 to 2020. Mr. Kacker received his undergraduate degree from Stanford University in 2002. |
| Jonathan Sheena |
Jonathan Sheena was the founder of PhoneSpots, Inc. (founded in 1999) where he held the title of Chief Technology Officer & VP-Product Management from 1999 to 2007. He is also the founder of Natera, Inc. (founded in 2003) where he currently holds the title of Director since 2020. Additionally, Mr. Sheena is currently working as a Director at MyOme, Inc. There are no former job titles mentioned for Mr. Sheena. He completed his undergraduate degree in 1994 and his graduate degree in 1996 from the Massachusetts Institute of Technology. |
| Eric A. Evans |
Eric A. Evans was the founder of Myriad Women's Health, Inc. (founded in 2007), where he held the title of Chief Science Officer & Director until 2018. He is currently the Chief Scientific Officer at Natera, Inc. (since 2020). Dr. Evans's former position was as Chief Scientific Officer-Myriad Women Health at Myriad Genetics, Inc. Dr. Evans holds a doctorate degree from Stanford University and an undergraduate degree from the University of Delaware. |
| Minetta Liu |
Minetta Liu is currently the Chief Medical Officer-Oncology at Natera, Inc. Prior to this, she worked as a Professor-Oncology at Mayo Clinic from 2012 to 2022. Liu completed her undergraduate degree at Princeton University and her doctorate at Sidney Kimmel Medical College. |
| Olesya A. Anisimova |
Olesya A. Anisimova is currently working as the Chief Accounting Officer at Natera, Inc. |
| Matthew Rabinowitz |
Matthew Rabinowitz was the founder of Rosum Corp. (founded in 2000) where he held the title of Chief Technology Officer from 2003 to 2007. He was also the founder of Panop.com, Inc. (founded in 1998) where he served as Chief Scientist from 1998 to 2000. Additionally, Dr. Rabinowitz is the founder of Natera, Inc. (founded in 2003) and currently holds the position of Executive Chairman since 2019. Dr. Rabinowitz is also the founder of MyOme, Inc... He currently holds the position of Director at GenEdit, Inc. and Acmg Foundation For Genetic & Genomic Medicine. Dr. Rabinowitz completed his undergraduate, graduate, and doctorate degrees at Stanford University. |
| Robert A. Schueren |
Robert A. Schueren is currently the Director at InterLink AI, Inc. He also holds the position of Independent Director at Olink Holding AB since 2022 and Chief Operating Officer at Natera, Inc. since 2019. In his former roles, Mr. Schueren served as the President, Chief Executive Officer & Director at IntegenX, Inc. from 2014 to 2018. He was also a Director at WaferGen Bio-systems, Inc. from 2014 to 2017. Additionally, he worked as the Deputy Global Head-Molecular Medicine at Genentech, Inc. from 2006 to 2010 and as the Vice President & GM-Genomics Solutions Division at Agilent Technologies, Inc. from 2010 to 2013. Mr. Schueren's education background includes an undergraduate degree from Temple University (Pennsylvania). |
| John Fesko |
John Fesko is currently the President & Chief Business Officer at Natera, Inc. Prior to his current position, he earned an undergraduate degree from the University of Notre Dame and an MBA from the Massachusetts Institute of Technology. |
| Solomon Moshkevich |
Solomon Moshkevich is currently the President-Clinical Diagnostics at Natera, Inc. He previously worked as a Consultant at Bain & Co., Inc. and as an Associate at Parthenon Capital LLC from 2007 to 2009. He also served as a Member at Organ-I, Inc. Mr. Moshkevich completed his undergraduate degree at The Trustees of Columbia University in The City of New York and holds an MBA from Stanford Graduate School of Business. |
| Herman Rosenman |
Herman Rosenman was the founder of Biofire Diagnostics, Inc. (founded in 2012) where he held the title of President, Chief Operating Officer & Director. He is currently a Director at Oxford Immunotec Ltd. (since 2013), Natera, Inc. (since 2014), Quest Diagnostics TB LLC (since 2013), Renaissance Medical Group, Inc., and DermTech, Inc. (since 2017). Previously, he held positions as President & Chief Executive Officer at RadNet Management, Inc. (1994-1997) and Ultra Acquisition Corp. (1997-2000). He was also a Director at Discovery Partners International, Inc. (2001-2006), ARYx Therapeutics, Inc. (2006-2011), and Infinity Pharmaceuticals, Inc. (2003-2007). Additionally, he served as Chief Financial Officer & SVP-Finance at Gen-Probe, Inc. (2001-2012) and was a Partner at Coopers & Lybrand LLP. He has also served as an Independent Director at VIVUS, Inc. and held various director positions at Medistem, Inc., Oxford Immunotec Global Ltd., DermTech Operations, Inc., Emphasys Medical, Inc., and Rexene Corp. Mr. Rosenman received an undergraduate degree from Pace University and an MBA from The Wharton School of the University of Pennsylvania. |
| Rowan E. Chapman |
Rowan E. Chapman is the founder of Initiate Studio LLC, which was founded in 2020. Dr. Chapman is also the founder of BEVC Management LLC and Initiate Studios LLC. Dr. Chapman's current job(s) include being an Independent Director at Evidation Health, Inc. since 2014, an Independent Director at Natera, Inc. since 2019, and a Director at Cornerstone AI, Inc. Dr. Chapman's former job(s) include being the Chairman of Vineti, Inc., a Director at Pacific Biosciences of California, Inc., Sequenta, Inc., HealthTap, Inc., Personalis, Inc., and Incyte Genomics Inc. Dr. Chapman was also the Head-Western North America & Australia Innovation at Johnson & Johnson from 2017 to 2019, a Partner at Mohr, Davidow Ventures LP from 2001 to 2012, a Board Observer at Verinata Health, Inc., ParAllele BioScience, Inc., and Adamas Pharmaceuticals LLC, the Head-Healthcare Investing at GE Ventures LLC, a Partner at MDV Management Co. LLC, the Head-Precision Diagnostics at GE UK Group from 2012 to 2016, and the Chief Business Officer at Dynamics Special Purpose Corp. Dr. Chapman's education includes undergraduate and doctorate degrees from the University of Cambridge. Dr. Chapman is also the founder of BEVC Management LLC, Initiate Studios LLC. |
| Ruth Williams-Brinkley |
Ruth Williams-Brinkley is currently a Director at DePaul University, the University of Phoenix, National Institutes of Health, Greater Washington Board of Trade, Greater Baltimore Committee, Natera, Inc., Greater Louisville, Inc., Diatherix Laboratories LLC, Travere Therapeutics, Inc., and a Member of The National Association of Health Services Executives. She is a former President & Chief Executive Officer at Carondelet Health Network, Memorial Health Care System Foundation, Inc., and KentuckyOne Health, Inc. She was also a Senior Vice President at CommonSpirit Health (Illinois) and a Director at Chattem, Inc. Additionally, she served as a Director at Kentucky Chamber of Commerce, Inc. and was briefly the President of Kaiser Foundation Health Plan of the Mid-Atlantic States, Inc. Ms. Williams-Brinkley received her undergraduate and graduate degrees from DePaul University. |
| Roy D. Baynes |
Roy D. Baynes is currently an Independent Director at Natera, Inc. and Travere Therapeutics, Inc. He is also a Member of the American Society of Clinical Oncology, Inc., the American Association for Cancer Research, and the American Society of Hematology. In addition, he serves as the Chief Medical Officer & Executive Vice President at Eikon Therapeutics, Inc. Previously, he held positions as an Independent Director at Atara Biotherapeutics, Inc., VP-Global Development & Head-Hematology Oncology at Amgen, Inc., SVP-Oncology, Inflammation & Respiratory at Gilead Sciences, Inc., and Chief Medical Officer at Merck & Co., Inc. He was also a Professor at the Barbara Ann Karmanos Cancer Institute. Baynes received a graduate degree and a doctorate from the University of the Witwatersrand. |
| Gail B. Marcus |
Gail B. Marcus is currently the Chairman at Biomodal Ltd. and an Independent Director at Natera, Inc., binx health, inc., Day Zero Diagnostics, Inc., and PathAI, Inc. She is also a Director at Engineering World Health, Team Better, LLC, Binx Health Ltd., and Strong Room Technology Pty Ltd. In the past, she served as the President & Chief Executive Officer at Inform Diagnostics, Inc. and Calloway Laboratories, Inc. She was also an Assistant Professor at Hofstra University and Massachusetts College of Pharmacy & Health Science. Dr. Marcus holds a doctorate degree from the Medical University of South Carolina, an undergraduate degree from Wesleyan University, and an MBA from The Wharton School of the University of Pennsylvania. |
| James Irvin Healy |
James Irvin Healy is currently the Chairman at Y-mAbs Therapeutics, Inc. He is also a Director at Sorbent Therapeutics, Inc., Bolt Biotherapeutics, Inc., Iterum Therapeutics International Ltd., Iterum Therapeutics US Holding Ltd., Atsena Therapeutics, Inc., Arrivent BioPharma, Inc., Rapport Therapeutics, Inc., Sofinnova Venture Partners VII LP, Sofinnova Management VI LLC, Sofinnova Management VII LLC, and Sofinnova Investments, Inc. He has previously held positions as the Chairman at Hyperion Therapeutics, Inc., Vice Chairman at Auris Medical AG and Auris Medical Holding AG, Independent Non-Executive Director at Amarin Corp. Plc, Independent Director at InterMune, Inc., Independent Director at Humanigen, Inc., Independent Director at Anthera Pharmaceuticals, Inc., Director at CoTherix, Inc., Director at Novacea, Inc., Director at Movetis NV, Director at PregLem SA, Independent Director at Ascendis Pharma A, Independent Director at Durata Therapeutics, Inc., Independent Non-Executive Director at NuCana Plc, Independent Director at Coherus BioSciences, Inc., Independent Director at ObsEva SA, Independent Director at Iterum Therapeutics Plc, Director at CinCor Pharma, Inc., and Independent Director at Karuna Therapeutics, Inc. He has also worked as a Manager at ISTA Pharmaceuticals, Inc. and an Associate at Sanderling Management CO LLC. Dr. Healy received his undergraduate degree from the University of California, Berkeley and his doctorate degree from Stanford University School of Medicine. |
